[{"address1": "1111 Lincoln Road", "address2": "Suite 500", "city": "Miami Beach", "state": "FL", "zip": "33139", "country": "United States", "phone": "786 977 3380", "website": "https://www.pasithea.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Pasithea Therapeutics Corp., a clinical-stage biotechnology company, focuses on the discovery, research, and development of treatments for central nervous system (CNS) disorders, RASopathies, and cancers. Its lead product candidate is PAS-004, a next-generation macrocyclic mitogen-activated protein kinase, or MEK inhibitor to treat a range of RASopathies, including neurofibromatosis type 1 (NF1); MAPK pathway-driven tumors, such as BRAFv600 and BRAF fusion tumors; and ETS2 driven diseases, including inflammatory bowel disease (IBD), primary sclerosing cholangitis, and ankylosing spondylitis. The company's lead development candidate is PAS-003, to treat amyotrophic lateral sclerosis. It also intends to develop PAS-001, to treat schizophrenia. Pasithea Therapeutics Corp. was incorporated in 2020 and is headquartered in Miami Beach, Florida.", "fullTimeEmployees": 4, "companyOfficers": [{"maxAge": 1, "name": "Dr. Lawrence  Steinman BA, M.D., Ph.D.", "age": 76, "title": "Co-Founder, MD & Executive Chairman", "yearBorn": 1948, "fiscalYear": 2024, "totalPay": 250000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Tiago Reis Marques M.D., Ph.D.", "age": 47, "title": "CEO & Director", "yearBorn": 1977, "fiscalYear": 2024, "totalPay": 450000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Daniel H. Schneiderman", "age": 46, "title": "Chief Financial Officer", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": 330000, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.13, "open": 1.091, "dayLow": 0.94, "dayHigh": 1.12, "regularMarketPreviousClose": 1.13, "regularMarketOpen": 1.091, "regularMarketDayLow": 0.94, "regularMarketDayHigh": 1.12, "payoutRatio": 0.0, "beta": 0.539, "forwardPE": -1.387324, "volume": 1694079, "regularMarketVolume": 1694079, "averageVolume": 5590116, "averageVolume10days": 23156860, "averageDailyVolume10Day": 23156860, "bid": 1.0, "ask": 1.0, "bidSize": 1, "askSize": 1, "marketCap": 2664681, "fiftyTwoWeekLow": 0.91, "fiftyTwoWeekHigh": 7.69, "fiftyDayAverage": 1.3052, "twoHundredDayAverage": 3.03922, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -3865781, "profitMargins": 0.0, "floatShares": 2592399, "sharesOutstanding": 2705260, "sharesShort": 416938, "sharesShortPriorMonth": 7889, "sharesShortPreviousMonthDate": 1741910400, "dateShortInterest": 1744675200, "sharesPercentSharesOut": 0.1541, "heldPercentInsiders": 0.08993, "heldPercentInstitutions": 0.04968, "shortRatio": 0.09, "shortPercentOfFloat": 0.16780001, "impliedSharesOutstanding": 2705260, "bookValue": 10.603, "priceToBook": 0.09289824, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -13904584, "trailingEps": -12.69, "forwardEps": -0.71, "lastSplitFactor": "1:20", "lastSplitDate": 1704153600, "enterpriseToEbitda": 0.284, "52WeekChange": -0.85286456, "SandP52WeekChange": 0.08001411, "quoteType": "EQUITY", "currentPrice": 0.985, "recommendationKey": "none", "totalCash": 6922729, "totalCashPerShare": 2.559, "ebitda": -13600933, "totalDebt": 0, "quickRatio": 6.182, "currentRatio": 6.58, "returnOnAssets": -0.42228, "returnOnEquity": -0.72835, "freeCashflow": -9000477, "operatingCashflow": -13923438, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "KTTA", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "REGULAR", "shortName": "Pasithea Therapeutics Corp.", "longName": "Pasithea Therapeutics Corp.", "ipoExpectedDate": "2021-09-15", "cryptoTradeable": false, "corporateActions": [], "regularMarketTime": 1746724555, "exchange": "NCM", "messageBoardId": "finmb_702706441", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "earningsTimestamp": 1742846400, "earningsTimestampStart": 1747080000, "earningsTimestampEnd": 1747425600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -12.69, "epsForward": -0.71, "fiftyDayAverageChange": -0.32019997, "fiftyDayAverageChangePercent": -0.24532637, "twoHundredDayAverageChange": -2.0542202, "twoHundredDayAverageChangePercent": -0.67590374, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1631712600000, "regularMarketChange": -0.14499998, "regularMarketDayRange": "0.94 - 1.12", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 5590116, "fiftyTwoWeekLowChange": 0.07499999, "fiftyTwoWeekLowChangePercent": 0.08241757, "fiftyTwoWeekRange": "0.91 - 7.69", "fiftyTwoWeekHighChange": -6.705, "fiftyTwoWeekHighChangePercent": -0.8719116, "fiftyTwoWeekChangePercent": -85.28645, "regularMarketChangePercent": -12.831857, "regularMarketPrice": 0.985, "displayName": "Pasithea Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-05-08"}]